Literature DB >> 16488780

What's next for the hepatitis A vaccine?

David B Rein1, Anthony E Fiore, Beth P Bell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16488780     DOI： 10.1016/S0140-6736(06)68196-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  The cost-effectiveness of universal vaccination of children against hepatitis A in Argentina: results of a dynamic health-economic analysis.

Authors:  Eduardo Lopez; Roberto Debbag; Laurent Coudeville; Florence Baron-Papillon; Judith Armoni
Journal:  J Gastroenterol       Date:  2007-03-12       Impact factor: 7.527

Review 2.  Live attenuated hepatitis A vaccines developed in China.

Authors:  Zhi-Yi Xu; Xuan-Yi Wang
Journal:  Hum Vaccin Immunother       Date:  2013-11-26       Impact factor: 3.452
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.